Haidilao Founders Sold Stake When Stock is Hot
(Bloomberg) -- While a lot of the follow-on offerings in Asia, and especially Australia, are from companies raising capital to weather the economic disruptions caused by the pandemic, in Hong Kong most of the recent deals have been shareholders monetizing their stakes.
The latest example? The founders of China's biggest hotpot chain, Haidilao International Holding Ltd., raised $201 million overnight through the sale of a roughly 0.9% stake. The sellers include units controlled by co-founder Zhang Yong and his wife Shu Ping. It's the first follow-on offering for the popular hotpot chain since its successful Hong Kong initial public offering in 2018. The stock has almost doubled since, making it an opportune time to sell.
Haidilao's shares tumbled earlier this year as the coronavirus outbreak in China forced the closure of its stores, but since the end of March they have staged a recovery and the company has said it will gradually reopen 85 stores in 15 Chinese cities.
Companies and their shareholders have raised $9.5 billion selling shares in Hong Kong since the start of the year, data compiled by Bloomberg show. Of that, $5.39 billion is from the sale of existing shares, while $4.23 billion has been raised through primary share placements, the data show. Since April the balance has shifted further: $2.41 billion has been raised by shareholders selling stakes, more than double the amount obtained by companies seeking funds.
No doubt a market recovery since a March 23 low has prompted shareholders to seize what may be a short market window, as uncertainties still abound on the economic repercussions of the coronavirus on the world economy. South Korea's SK E&S Co. Ltd. sold all of its remaining stake in China Gas Holdings in a massive $1.9 billion block trade on April 17.
The follow-on activity in Hong Kong stands in sharp contrast to that in Australia, where firms have raised a total of $8.1 billion since April 1 selling new shares, with no sales of existing stock.
UPCOMING LISTINGS:
- Central China New Life Ltd.
- Hong Kong stock exchange
- Size up to $279m
- Expected pricing May 8, trading May 15
- BNP Paribas, Morgan Stanley
- Kingsoft Cloud Holdings Ltd.
- Nasdaq exchange
- Size up to $450m
- Expected pricing May 7, trading May 8
- JPMorgan, UBS, Credit Suisse, CICC
- Peijia Medical Technology Co.
- Hong Kong stock exchange
- Size $302m
- Trading May 15
- Morgan Stanley, Huatai
- Kintor Pharmaceutical Ltd.
- Hong Kong stock exchange
- Size up to $300m
- Pre-marketing from April 27
- Huatai, UBS
- Ebang International Holdings Inc.
- New York
- Size $100m
- Filed April 25
- AMTD, Loop Capital Markets
- Weimob Inc. sells $150M 1.50% convertible bonds due 2025
- Cancer drug developer Kintor Pharmaceutical Ltd. is in talks with potential cornerstone investors including Chinese appliance giant Gree Group for its $200 million Hong Kong initial public offering, people familiar with the matter said
- GlaxoSmithKline Plc is selling its entire stake in Unilever's listed India unit for about $3.3 billion, according to terms seen by Bloomberg
- Yes Bank aims to raise INR100B-120B in equity capital by mid-July
- Asia ECM Weekly Agenda
- IPO data
- U.S. ECM Watch
- EU ECM Watch
- To receive the ECM Watch in your inbox daily, click the “subscribe” button at the top of this article
More ECM situations we are following:
See also:
©2020 Bloomberg L.P.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.